Rocaltrol and Cachexia - a phase IV clinical study of FDA data

Summary:

Cachexia is reported as a side effect among people who take Rocaltrol (calcitriol), especially for people who are female, 60+ old, also take Lasix, and have Hepatitis.

The phase IV clinical study analyzes which people have Cachexia when taking Rocaltrol. It is created by eHealthMe based on reports of 7,521 people who have side effects when taking Rocaltrol from the FDA, and is updated regularly.

What is Rocaltrol?

Rocaltrol has active ingredients of calcitriol. It is often used in hypoparathyroidism. eHealthMe is studying from 7,562 Rocaltrol users. Check the latest studies of Rocaltrol.

What is Cachexia?

Cachexia (loss of weight) is found to be associated with 662 drugs and 1,202 conditions by eHealthMe. Check the latest studies of Cachexia.

On Jun, 23, 2026

7,521 people reported to have side effects when taking Rocaltrol.
Among them, 13 people (0.17%) have Cachexia.

Among these 13 people:

What is the gender of people who have Cachexia when taking Rocaltrol? *

female: 84.62 %
male: 15.38 %

What is the age of people who have Cachexia when taking Rocaltrol? *

What are other drugs people take besides Rocaltrol? *

What are other side effects people have besides Cachexia? *

Nausea (feeling of having an urge to vomit): 5 people, 38.46%
Pain: 5 people, 38.46%
Atherosclerosis (disorder of the arteries): 5 people, 38.46%
Constipation: 4 people, 30.77%
Coagulation Test Abnormal: 4 people, 30.77%
Nephrosclerosis (hardening of the kidney due to renovascular disease): 4 people, 30.77%
Hypotension (abnormally low blood pressure): 4 people, 30.77%
High Blood Pressure: 4 people, 30.77%
Confusional State: 4 people, 30.77%
Pulmonary Hypertension (increase in blood pressure in the lung artery): 4 people, 30.77%

What are the existing conditions these people have? *

Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 3 people, 23.08%
Osteoporosis (bones weak and more likely to break): 3 people, 23.08%
Hypoaesthesia (reduced sense of touch or sensation): 3 people, 23.08%
Hepatitis (inflammation of the liver): 3 people, 23.08%
Hyperparathyroidism (an abnormally high concentration of parathyroid hormone in the blood, resulting in weakening of the bones through loss of calcium): 2 people, 15.38%
Pancreatic Neuroendocrine Tumor: 1 person, 7.69%
Ischaemic Cardiomyopathy (weakness in the muscle of the heart due to inadequate oxygen delivery to the myocardium with coronary artery disease): 1 person, 7.69%
Hyperparathyroidism Secondary (an abnormally high concentration of parathyroid hormone in the blood, resulting in weakening of the bones through loss of calcium-secondary): 1 person, 7.69%
High Blood Pressure: 1 person, 7.69%
Heart Rate Irregular: 1 person, 7.69%

* Approximation only. Some reports may have incomplete information.

Do you take Rocaltrol and have Cachexia?

- Check whether Cachexia is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Rocaltrol:

Rocaltrol (7,562 reports)

Cachexia treatments and more:

Cachexia (7,763 reports)

Browse all side effects of Rocaltrol:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Cachexia:

Cachexia (662 drugs)

Browse all the conditions that are associated with Cachexia:

Cachexia (1,202 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on calcitriol (the active ingredients of Rocaltrol) and Rocaltrol (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.